Jonathan Winger

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

Matternet, Inc. develops drones for its delivery vans. It offers Matternet M2, a drone logistics system that features automatic payload and battery exchange, intelligent routing and monitoring, precision landing, and intuitive command and control. The company was founded by Andreas Raptopoulos, Darlene Damn, Dimitar Pachov, and Paola Santana in 2011 and is headquartered in Menlo Park, CA.

Cellsonics, Inc. engages in development of a next generation single cell isolation. The company is headquartered in Newark, DE.

Trident Labs, Inc. engages in the operation of toxicology laboratories. It offers urine and oral fluid drug testing to help medical offices monitor adherence to prescription medication and abstinence from illicit drugs. The company is headquartered in Holland, MI.

xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA.

Microsonic Systems, Inc. develops acoustics-based instruments for biotech and pharmaceutical industries. It offers ultrasonic fluid processing devices including Microsonics ST30, a personal deoxyribonucleic acid sample preparations system; and HENDRIX SM100, a ultrasonic fluid processor. The company was founded by Steven Horwitz on August 24, 2004 and is headquartered in San Jose, CA.

American Committee for the Weizmann Institute of Science operates as a community of visionary people who advance the partnership between science and philanthropy. It partners with individuals, families, foundations, and the business community to develop philanthropic funding for the institute; educates the American public about the institute’s research; and represents the institute’s interests in the U.S. through the events such as galas, parlor meetings, and luncheons; meetings with institute scientists and campaigns to spread the news of research discovery. The company was founded by Chaim Weizmann in November 1944 and is headquartered in New York, NY.

Cancer Commons is a non-profit organization that provides compassionate support for people with advanced or metastatic cancer. The private company is based in Palo Alto. The American company's services include leading-edge care navigation and personalized action plan creation for people with advanced or metastatic cancer. Founded in 2012, the company works one-on-one with patients and caregivers to surface the best-possible action plan for anyone dealing with advanced cancer.

TOMA Biosciences, Inc. develops and provides DNA-based cancer testing technology. The company was founded by Hanlee Ji, Lincoln Nadauld, James M. Ford, and Calvin J. Kuo in 2011 and is headquartered in Foster City, CA.

PharmaJet, Inc. operates as a medical device company which develops needle-free injection technology. Its products include Tropis needle-free injector device, and flu and polio application. The company was founded by Heather Callender-Potters and Kathleen Callender in 2005 and is headquartered in Golden, CO.

Ensim Corp. provides software solutions for unified communications and collaboration infrastructure. It offers solutions to manage and automate private and public cloud, user entitlement, provisioning, billing, and customer support for applications and services. The firm’s technologies including unified communications (UC), virtual desktops and servers, hosted cloud applications (SaaS), email, instant messaging, VoIP, collaboration, database, and website hosting environments can be subscribed, provisioned, automated, secured, compliant, self-managed, invoiced, and policy controlled with Ensim products. The company was founded was founded by Srikanth Chari, Samir Mathur, Xun Wilson Huang, Srinivasan Keshav, Rosen Sharma and Snorri Gylfason in 1998 and is headquartered in Sunnyvale, CA.

Theracaine LLC engages in the provision of healthcare services. The company was founded in 2016 and is headquartered in San Francisco, CA.

Demoflow, Inc. operates as a demo enablement platform. It streamlines prep, presentation, follow-up, and documentation for product demo. The company is headquartered in Denver, CO.

Veran Medical Technologies, Inc. designs, develops, and markets soft tissue equipment. The firm's main focus is assisting physicians in the early diagnosis and treatment of lung cancer. The company was founded by Ben Heavrin, Bruce Lynskey, Jerome R. Edwards, and Evan Austill, Jr. in 2005 and is headquartered in St. Louis, MO.

EpiRay, Inc. designs and develops ultra short pulse laser technology solutions. The company is headquartered in Palo Alto, CA.

NaNotics LLC develops nanomedical platform for treating major human and animal diseases. It provides NaNots a new nano-medical platform consisting of in vivo “extractors” that deplete from blood specific molecular signals or signal inhibitors that drive or enable disease progression. The company was founded by Lou Hawthorne and John Dodgson and is headquartered in Mill Valley, CA.

Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY.

Enable Medicine, Inc. is a company that aims to make biology more searchable. The company is based in Menlo Park, CA. The company has generated and indexed over a petabyte of data and are studying over 20 diseases across 75 scientific studies. The company works with researchers at institutions worldwide to develop scientific and clinical insights to better understand complex biology. The company's goal is to index and map biology to guide therapeutics discovery and development. The company was founded by Aaron Mayer. The CEO is Sunil Bodapati.

Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA.

Orsobio, Inc. is a clinical-stage biopharmaceutical company that focuses on developing therapies to treat obesity and other severe metabolic disorders, such as type 2 diabetes, NASH, and severe dyslipidemias. The company is based in Palo Alto, CA. The company has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism. Orsobio has a team of physicians and scientists who are dedicated to developing therapies to treat organ failure in patients with severe metabolic disorders. The company was founded by Mani Subramanian, who has been the CEO since incorporation.

Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC).

Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California.

Covid Apollo Project LLC aims to facilitate a safe and sustainable return to work and school by identifying, assembling, developing, and scaling the most promising COVID-19 diagnostic opportunities. Covid Apollo Project is based in Boston, MA. The private company was organized and funded under the leadership of RA Capital, a biotechnology-focused investment firm, in collaboration with Redmile Group, Samsara Biocapital, Perceptive Advisors, and Bain Capital. The CEO of the company is Stefan Willemsen.

Tentarix Biotherapeutics LP operates as a biotechnology company. The company is headquartered in La Jolla, CA.

Nalo Therapeutics, Inc. is a company that focuses on developing therapeutics to address unmet needs in cancer. Nalo Therapeutics is based in Belmont, CA and the CEO of the company is Keith Wilson. The company targets oncogenic driver mutations and/or proteins that are often difficult to drug. The company was founded in 2017 and collaborates with UCSF scientific cofounders.

Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY.

Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden.

Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA.

Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.

Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.